Ph 2B/3 Tafenoquine (TFQ) Study in Prevention of Vivax Relapse
Clinical trial NCT01376167 · COMPLETED
Trial details
- NCT number
- NCT01376167
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-24
- Primary completion
- 2016-11-18
- Enrollment
- 851
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.